Top Glove Corporation Bhd
SGX:BVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (1.2), the stock would be worth S$0.22 (4% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.2 | S$0.23 |
0%
|
| 3-Year Average | 1.2 | S$0.22 |
-4%
|
| 5-Year Average | 1.3 | S$0.24 |
+3%
|
| Industry Average | 1.1 | S$0.2 |
-14%
|
| Country Average | 1.3 | S$0.25 |
+7%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| MY |
T
|
Top Glove Corporation Bhd
SGX:BVA
|
5.9B SGD | 1.2 | 42.1 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 9.5 | 39.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.8B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.9B CHF | 1.7 | 37.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
93.1B DKK | 6.7 | 23.1 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 3.3 | 33 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 3.7 | 32.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 0.9 | -15.5 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.8B CNY | 2.1 | 22.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
879B JPY | 5.6 | 49.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.3B CNY | 4.3 | 22.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.8 |
| Median | 1.3 |
| 70th Percentile | 2.5 |
| Max | 2 591.7 |
Other Multiples
Top Glove Corporation Bhd
Glance View
Nestled in the bustling industrial landscape of Malaysia, Top Glove Corporation Bhd has emerged as a pivotal player in the global healthcare supply chain. Founded in 1991 by Tan Sri Dr. Lim Wee Chai, what began as a modest enterprise with a singular production line has transformed into the world's largest manufacturer of gloves. The company’s remarkable journey is powered by its commitment to innovation, stringent quality control, and a relentless drive to expand its production capacity. With operations spanning several countries, Top Glove’s manufacturing capabilities cater to a variety of glove types, including latex, nitrile, and vinyl, addressing the diverse needs of healthcare professionals across the globe. Top Glove operates on a high-volume, low-margin business model, allowing it to thrive in an industry that demands both reliability and cost-effectiveness. The company generates revenue by selling its products to an extensive network of distributors, healthcare institutions, and retailers worldwide. Its strategic approach to cost management and supply chain efficiency enables Top Glove to maintain competitive pricing while ensuring significant profit margins. By continuously investing in technology upgrades and expanding its production facilities, Top Glove ensures it remains at the forefront of the glove manufacturing sector, adeptly navigating the vicissitudes of global health trends and economic cycles.
